Braskem S.A. (BAK) ranks among the largest producers of thermoplastic resins including polyethylene, polypropylene, and PVC, with operations spanning Brazil, the United States, Europe, and Mexico. Profitability depends heavily on the spread between resin prices and feedstock costs, so each quarterly release offers a direct window into the global petrochemical cycle. The company continues to manage a prolonged industry downturn driven by overcapacity while also addressing its capital structure and elevated leverage. In my view, the upcoming print will matter most for signals on cost discipline, demand trends in Brazil, and whether restructuring efforts can ease balance-sheet pressure that has weighed on the ADR.
MarketBeat consensus calls for third-quarter 2026 EPS of about $0.02 and revenue near $3.64 billion, marking a double-digit increase from roughly $3.17 billion in the year-ago quarter. Other aggregators show somewhat higher per-share figures, reflecting dispersion among the limited analyst coverage. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry. Recurring EBITDA will draw close attention after the second-quarter 2026 figure reached approximately $1.04 billion on a temporary Brazil-segment boost tied to Middle East supply issues. Management has already noted those gains were tactical rather than structural, so investors will track utilization rates across regions, resin volumes, and any fresh updates on debt negotiations.
Caution prevails as shares have faced pressure from weak global polyethylene demand, ongoing overcapacity, and restructuring uncertainty. Some trackers show a negative post-earnings drift after the August 2026 release, suggesting the market has been quick to temper near-term optimism. Main risks include further spread compression, softer Brazilian resin demand, and possible dilution from restructuring. On the positive side, operational gains in Mexico and tighter cost control could support a steadier tone.
The path of petrochemical spreads will dominate the outlook, with management already highlighting an oversupplied polyethylene market. Any renewed pressure on resin prices versus naphtha or ethane costs would weigh on margins through year-end. Operationally, utilization rates and the ethane supply ramp in Mexico via Braskem Idesa deserve attention, as does domestic resin demand and the green polyethylene segment in Brazil. Capital-structure developments—bank and bondholder talks, out-of-court terms, and dilution risks—will likely influence the stock more than a single quarter’s EBITDA. Updates on the long-term ethane agreement with Petrobras and the broader transformation program will also help assess whether cyclical relief can translate into lasting recovery.
I’ve found Tickeron’s AI Daily Buy/Sell Signals helpful for gauging momentum around earnings events like this one. The platform lets me review automated signals and historical patterns quickly, which adds useful context when comparing BAK to peers in the materials sector. It’s become a regular part of how I cross-check ideas without replacing my own fundamental work.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
BAK saw its Momentum Indicator move above the 0 level on November 09, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 78 similar instances where the indicator turned positive. In 62 of the 78 cases, the stock moved higher in the following days. The odds of a move higher are at 79%.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where BAK's RSI Indicator exited the oversold zone, 36 of 51 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 71%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 57 of 75 cases where BAK's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 76%.
Following a +5.66% 3-day Advance, the price is estimated to grow further. Considering data from situations where BAK advanced for three days, in 187 of 253 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.
BAK may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Moving Average Convergence Divergence Histogram (MACD) for BAK turned negative on October 26, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In 36 of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at 78%.
BAK moved below its 50-day moving average on October 15, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BAK declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.
The Tickeron Valuation Rating of 1 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: BAK's P/B Ratio (-0.035) is slightly lower than the industry average of (1.147). P/E Ratio (-0.078) is within average values for comparable stocks, (3.243). Projected Growth (PEG Ratio) (0.030) is also within normal values, averaging (3.769). BAK's Dividend Yield (2.475) is considerably higher than the industry average of (0.195). P/S Ratio (0.051) is also within normal values, averaging (0.578).
The Tickeron PE Growth Rating for this company is 9 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 91 (best 1 - 100 worst), indicating slightly worse than average price growth. BAK’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BAK’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufacturer of petrochemicals and other related products
Industry ChemicalsMajorDiversified